Actinium Pharmaceuticals, Inc.
ATNM- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001388320
No open-market purchases or sales by Actinium Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $5.18M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Actinium Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 65 | 71 | +6 |
| Shares | 4.74M | 6.04M | +1.30M (+27.3%) |
| Value | $45.0M | $44.8M | −$125.9K (−0.3%) |
New holders (23)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (17)
Institutions that held Actinium Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 231,172 | $2.19M |
| Marshall Wace, LLP | 74,355 | $702.7K |
| HRT Financial LP | 62,533 | $590.0K |
| Qube Research & Technologies Ltd | 58,339 | $551.3K |
| Cantor Fitzgerald, L. P. | 40,000 | $378.0K |
| Virtu Financial LLC | 21,650 | $205.0K |
| Verition Fund Management LLC | 17,516 | $165.5K |
| LMR Partners LLP | 16,943 | $160.1K |
| 683 Capital Management, LLC | 16,000 | $151.2K |
| Man Group plc | – | $115.5K |
| Interchange Capital Partners, LLC | 11,413 | $107.9K |
| Boothbay Fund Management, LLC | 10,135 | $95.8K |
| Cutler Group LP | 4,058 | $38.0K |
| UBS Group AG | 2,704 | $25.6K |
| Advisory Services Network, LLC | 1,500 | $14.2K |
| The PNC Financial Services Group, Inc. | 1,000 | $9.45K |
| TCI Wealth Advisors, Inc. | 100 | $945 |